Pixal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pixal

Quick Facts

Property Description
Active ingredient Levocetirizine dihydrochloride
Form Film-coated tablets, Oral solution
Pharmacological class Second-generation H1-receptor antagonist
General purpose Systematic relief of allergic symptoms
Origin Synthetic, purified enantiomer

What is Pixal? Defining the Antihistamine Entity

Pixal is a single-component, oral medication whose core active ingredient is Levocetirizine. It is classified as a second-generation histamine H1-receptor antagonist, which is a type of anti-allergic agent that acts by blocking the effects of histamine. It acts as a highly selective inhibitor of H1-receptors, which are integral to the bodily cascade that produces allergy symptoms.

Chemically, Levocetirizine is defined as a synthetic, purified compound: the active (R)-enantiomer of Cetirizine. This composition means the drug is the therapeutically beneficial isomer isolated from the older racemic mixture, a structural refinement that differentiates it from its predecessor. It is characterized by a superior H1-receptor binding affinity compared to its racemate. This property makes the drug targeted in its action against allergic response triggers.

Composition, Form, and General Purpose

The medication is supplied as a single-ingredient product, containing only Levocetirizine dihydrochloride as the active substance. It is designed for the oral route of administration and is commonly available in two forms: film-coated tablets and an oral solution, providing options for both adult and pediatric patients. Levocetirizine's status as a purified compound is used in the management of the widespread symptoms that characterize allergic episodes, such as chronic itchy skin or seasonal irritation.

The general purpose of this specific H1-antagonist is the systematic relief of physical manifestations that result from the excessive release of histamine. By preventing histamine from activating its receptors, Levocetirizine works to reduce widespread allergic signs, including itching, swelling, and fluid exudation. Its pharmacological design as a second-generation agent ensures the therapeutic benefit is achieved with a minimal propensity for centrally mediated effects, which defines its utility in allergy management and allows for its common over-the-counter (OTC) status in many countries.

Regulatory References

  1. Levocetirizine Drug Information
  2. Levocetirizine: Pharmacology and Use

What side effects are possible with Pixal?

Possible Side Effects and Safety Information

The safety profile of Pixal (Levocetirizine), as documented in official government prescribing information, outlines known adverse reactions across various body systems. Side effects are classified by frequency, reflecting rates observed in clinical trials and post-marketing surveillance.


Frequency-Classified Adverse Reactions

Adverse reactions that are Common (occurring in 1/100 to 1/10 patients) include somnolence (drowsiness), fatigue, dry mouth, and headache. Reactions classified as Uncommon include asthenia (lack of strength), abdominal pain, and pruritus (itching). Rare reactions include hypersensitivity and convulsions.

System-Organ Class Examples of Documented Adverse Reactions
Nervous System Somnolence, Headache, Dizziness
Gastrointestinal Dry mouth, Abdominal pain, Nausea
Immune System Hypersensitivity, Anaphylaxis (rare)
Psychiatric Aggression, Hallucinations, Suicidal ideation (post-marketing)
Renal/Urinary Urinary retention (post-marketing)

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions cited in regulatory documents include Anaphylaxis, which is a severe immune reaction, and post-marketing reports of events such as Urinary Retention and Suicidal Ideation. The medicine is contraindicated in individuals with known hypersensitivity to the drug or its components. Safety notes advise that use may result in further impairment of CNS performance when taken concurrently with alcohol or other central nervous system depressants.

Population-Specific Notes

The medicine is contraindicated in patients with End-Stage Renal Disease and in pediatric patients (6 months to 11 years) with impaired renal function, reflecting the drug's primary excretion route. Caution is also advised for older adults due to the higher likelihood of reduced renal function in this population. Additionally, reports of severe pruritus (itching) have occurred upon discontinuation following long-term use.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Pixal (Levocetirizine) overdose focuses on specific Central Nervous System (CNS) manifestations and mandated emergency protocols. Any suspicion of over-exposure requires immediate medical attention.

Overdose Scope

Feature Official Regulatory Statement
Documented Manifestations In adults, overdose is primarily characterized by somnolence (drowsiness). In children, a distinct biphasic pattern of initial agitation and restlessness is documented, followed by drowsiness.
Emergency-Response Treatment must be symptomatic and supportive. There is no known specific antidote for Levocetirizine overdose.

Management and Clinical Focus

Official guidance directs that supportive measures should be instituted immediately. While hemodialysis is not effective for removing the drug, procedures such as gastric lavage or the administration of activated charcoal should be considered following substantial over-exposure. Due to the potential for severe effects in massive overdose, cardiac monitoring may be deemed necessary by healthcare professionals.

Connection to the overall overdose profile: Regulatory documentation defines the overdose profile primarily through expected CNS effects and the explicit lack of a specific antidote. This structure mandates seeking emergency medical care to ensure supportive treatment is initiated and to manage the documented clinical manifestations, especially the differentiated presentation in pediatric patients.

Therapeutic Uses of Pixal

What Pixal treats: Main Uses and Benefits

Pixal's active ingredient, Levocetirizine, is commonly used to help with symptomatic relief in allergic rhinitis (both seasonal and perennial) and for addressing skin manifestations of chronic idiopathic urticaria (hives). The drug is utilized for providing supportive symptomatic relief for conditions presenting with systemic or localized discomfort.


Symptom Management and Clinical Contexts

Pixal is generally applied across therapeutic domains where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms. The core therapeutic applications are used for managing the clusters of symptoms related to allergic rhinitis, which includes persistent sneezing, a runny or itchy nose, and associated symptoms of ocular itching. It is also relevant for easing the persistent skin symptoms of Chronic Idiopathic Urticaria (CIU), such as widespread pruritus and the appearance of wheals. The medication assists in managing functional stability when symptoms interfere with routine activities.

“The primary goal is to provide supportive relief that helps patients cope more steadily with symptom fluctuations.”


Quick Fact Block

Quick Fact: Relief for Key Symptoms
Primary Symptom Domains Symptoms related to physical discomfort (oculonasal and dermal pruritus)
Targeted Conditions Conditions involving episodic or fluctuating manifestations (allergic rhinitis, CIU)
Patient Benefit Supports easing the overall symptom burden

Regulatory References

  1. NIH DailyMed Label

Eligibility and Restrictions for Use

This information is derived from the standardized eligibility criteria required by official government regulatory agencies for authorized medicines; however, specific label data for a drug named Pixal is not publicly available in official databases.

Contraindications and Eligibility Rules

The official eligibility profile for any regulated medicine is strictly defined by three core boundaries: absolute contraindications, age restrictions, and specific physiological conditions.

Eligibility Status Populations/Conditions
Use is Contraindicated [Data Not Found] (e.g., Hypersensitivity to the active substance)
Use Not Established [Data Not Found] (e.g., Pediatric patients under a specific age)
Use is Restricted [Data Not Found] (e.g., Severe hepatic or renal impairment)

Eligibility limitations explicitly define who must not use the medicine (e.g., absolute contraindications) and who requires restricted or conditional use (e.g., dose adjustments for older adults or those with organ impairment). Regulatory bodies also determine the official status for use during Pregnancy and Lactation, frequently classifying use as 'not recommended' or requiring assessment of maternal benefit versus fetal risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Pixal (Levocetirizine) around specific pharmacodynamic and pharmacokinetic considerations.


Documented Pharmacodynamic and Substance Interactions

Substance Category Interaction Effect (Official Statement)
Central Nervous System (CNS) Depressants Concurrent use with CNS depressants or alcohol may lead to additive reductions in alertness and additional impairment of CNS performance.
Allergy Skin Tests A wash-out period of approximately 3 days (72 hours) is mandatory before testing, as the medication inhibits the response to these diagnostic procedures.

Pharmacokinetic and Population-Related Notes

In interaction studies, co-administration of the racemate (Cetirizine) with Ritonavir or Theophylline resulted in documented changes to the clearance and extent of exposure of Cetirizine. However, in vitro data indicate that Levocetirizine is unlikely to produce pharmacokinetic interactions through inhibition or induction of liver drug-metabolizing enzymes (CYP system), as its metabolism is limited.

Since Pixal is substantially eliminated by the kidneys, its clearance is reduced in patients with impaired renal function, including geriatric subjects, which may increase the risk of reduced clearance if co-administered with other renally-eliminated substances. While taking the drug with food does not reduce the overall extent of absorption, it may decrease the rate of absorption.

Mechanism of Action

Selective Blockade of Serotonin and Norepinephrine Transporters

Pixal functions primarily as an inhibitor with high affinity for the Serotonin Transporter (SERT) and, to a lesser degree, the Norepinephrine Transporter (NET) on presynaptic nerve terminals. This mechanism prevents the reabsorption (reuptake) of the neurotransmitters serotonin (5-HT) and norepinephrine (NE) from the synaptic cleft. This action modulates serotonergic and noradrenergic signaling pathways by increasing the extracellular concentration of these monoamines.


Central Nervous System Adaptive Cascade

The chronic elevation of synaptic neurotransmitter concentrations triggers a time-dependent biological feedback mechanism: the down-regulation and desensitization of postsynaptic receptors over several weeks. This adaptive change in receptor activity in areas like the limbic system is a compensatory response to the chronic elevation of neurotransmitter levels. This process alters the signal transmission capacity within the affected neural pathways.


Peripheral Physiological Modulation

The SERT mechanism extends beyond the central nervous system, influencing other bodily functions. Inhibition of SERT on circulating platelets interferes with their serotonin uptake and subsequent aggregation capability. Additionally, the modulation of 5-HT levels in the gastrointestinal tract affects visceral motility and secretion. These peripheral actions result in changes to physiological functions due to the mechanism's involvement across organ systems.

Dosage and Administration Information

How to Use Pixal

Pixal, which contains levocetirizine dihydrochloride, is administered via the oral route using either the film-coated tablet or the oral solution. The medication is designed for once-daily usage and may be taken with or without food. The dose is generally taken in the evening.


Standard Dosage and Administration

The standard regimen for adults and adolescents 12 years of age and older consists of 5 mg taken once daily. A lower daily dose of 2.5 mg is sometimes utilized in some individuals, which can be achieved by utilizing the scored tablet form. For children aged 6 to 11 years, the recommended dose is a single daily administration of 2.5 mg.


Usage Patterns and Special Populations

Treatment duration is flexible depending on the clinical scenario. For conditions characterized by intermittent symptoms, administration may be stopped when symptoms subside and resumed if they recur. For persistent conditions, a continuous daily course is typically maintained.

Due to the drug’s renal elimination, dosage adjustments are specified for adults with reduced kidney function, based on creatinine clearance (CLCR). For example, a dose of 2.5 mg once every other day is required for individuals with moderate renal impairment (CLCR = 30-50 mL/min). The medication is typically contraindicated or not recommended in severe renal impairment or in pediatric patients with any degree of kidney impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Pixal


Evidence for use in Allergic Rhinitis (Seasonal and Perennial)

The foundation of the evidence base for Pixal was evaluated in numerous short-term, randomized controlled trials (RCTs). This research examined outcomes related to physical discomfort, focusing on conditions characterized by fluctuating or episodic manifestations of allergic rhinitis, such as seasonal hay fever or year-round (perennial) allergy symptoms.

Studies monitored change in patient-reported outcomes describing perceived discomfort, specifically using total nasal symptom scores (TNSS). Research highlights changes measured during the study period across these symptom axes, and findings describe patterns observed in the studies across the defined time intervals. While research contributes to understanding symptom patterns in the short-term, these results apply only to the populations studied and do not offer personal predictions.


Evidence for use in Chronic Idiopathic Urticaria (Hives)

For conditions involving periods of heightened symptoms such as Chronic Idiopathic Urticaria (CIU), research was studied for its role in skin manifestations. In these trials, researchers examined outcomes related to physical discomfort, specifically the severity of persistent itching (pruritus) and the appearance and size of wheals (hives).

Research highlights changes measured in the combined total symptom scores (TSS) over the course of the short-term studies. The measured outcomes related to symptom intensity were described as being present throughout the duration of the short-term trials. Most research was evaluated in adults and adolescents, and the results reflect the specific conditions under which they were conducted.


Long-term Studies and Durability of Outcomes

Most clinical trials supporting the initial evidence for Pixal were structured as short-term research, typically lasting between one and six weeks. Follow-up durations were limited for many of the core studies. Some larger observational settings evaluating daily-life functioning have studies monitored outcomes over periods extending up to six months. However, controlled evidence specifically designed to assess long-term effects are not fully established past the six-month mark in large, randomized study settings.

Key Studies & References

  1. Levocetirizine dihydrochloride tablet/solution (XYZAL) - FDA Package Insert/DailyMed

Frequently Asked Questions (FAQ)

Common questions about Pixal (FAQ)

Q: What is Pixal used for besides the main condition?

According to official regulatory documents, Pixal is approved for multiple uses. These include managing symptoms related to Seasonal Allergic Rhinitis (SAR), which is commonly known as hay fever, and Perennial Allergic Rhinitis (PAR), which involves year-round allergy symptoms. It is also indicated for the treatment of uncomplicated Chronic Idiopathic Urticaria (CIU), a form of persistent hives.

Q: Are there any specific foods or drinks that should be avoided when taking Pixal?

Official documents advise avoiding alcohol while using this medicine, as the combination may lead to an additive reduction in alertness and further impairment of performance. Regulatory information states that Pixal may be taken with or without food, although food might slightly delay how quickly the medicine starts to work.

Q: Can Pixal affect a person's sleep patterns?

Yes, official product information lists effects that can relate to sleep patterns. Somnolence (drowsiness) and fatigue are noted as common adverse reactions. Less common or rare reports post-marketing have included insomnia (difficulty sleeping) and nightmares.

Q: How long after starting Pixal should I begin to notice an expected effect?

Studies and official clinical pharmacology reviews indicate that the medicine begins working relatively quickly. The maximum effect in blocking the skin's response to histamine is typically observed within 1 hour after a dose is taken.

Q: Can Pixal be used by older adults?

Official product information advises caution for older adults. Since the medicine is primarily cleared by the kidneys, a dosage adjustment may be necessary due to the greater possibility of reduced kidney function in this age group.

Q: Is Pixal safe to take while breastfeeding, according to official information?

Official regulatory documents state that the active ingredient is known to be excreted into human milk. For this reason, use of the medicine is not recommended for women who are breastfeeding.

Q: Is there evidence that Pixal's effectiveness decreases over time?

Research supporting the initial evidence for Pixal mainly focused on short-term randomized trials, typically lasting up to six months. Controlled evidence specifically designed to assess long-term effects or a decrease in effectiveness over time is not fully established past that duration in the official studies.

Q: Why is Pixal prescribed for the treatment of [Core Condition]?

Pixal is classified as a highly selective H1-receptor antagonist. This means it works by targeting and blocking the effects of histamine, a naturally occurring chemical that is responsible for triggering the physical manifestations of allergic episodes.

Q: Does Pixal cause sun sensitivity or skin reactions?

Official documents list documented skin reactions, including rash and pruritus (itching). However, photosensitivity (or sun sensitivity) is not listed as an adverse reaction in the core regulatory product information.

Q: Can Pixal be cut or crushed to make it easier to swallow?

Official labeling states that the film-coated tablets are designed to be swallowed whole. For individuals who have difficulty swallowing tablets, the medicine is also available in an oral solution form.

Q: Does Pixal have a major interaction with common over-the-counter pain relievers?

Official drug interaction studies do not specifically report major interactions with common over-the-counter pain relievers, such as non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen. Documented interactions primarily focus on substances that affect the central nervous system or certain medicines that affect clearance.

Q: Does Pixal usually cause weight gain or weight loss?

Official reports of adverse reactions list both increased appetite and weight increased among the events reported post-marketing.

Q: What happens if I miss a dose of Pixal?

The official label provides instructions on managing a missed dose. It recommends taking the dose as soon as it is remembered. If it is almost time for the next scheduled dose, the instruction is to skip the missed dose and resume the regular daily schedule.

Q: Is Pixal known to interact with birth control pills?

Official drug interaction studies do not specify any known interactions between Pixal and oral contraceptives (birth control pills).

Q: What is the official classification of Pixal (e.g., controlled substance)?

According to regulatory bodies, the active ingredient in Pixal is not classified as a controlled substance. It is not subject to the rules of controlled drug regulations in the U.S. or international schedules.

Q: Are there any known drug interactions with supplements like St. John's wort or multivitamins?

Official documents state that specific interaction studies have not been conducted between Pixal and herbal supplements, such as St. John's wort, or multivitamins.

Q: Does Pixal require any special monitoring or lab tests while using it?

Official information indicates that monitoring is necessary for patients with known kidney impairment. The process involves checking creatinine clearance (CLCR), which is used to assess kidney function, in order to ensure that the correct dosage is being administered.

Q: Is Pixal likely to interact with medications for high blood pressure?

Official drug interaction studies do not specify any known interactions between Pixal and common anti-hypertensive (high blood pressure) medications.

Q: How long does Pixal stay in the body after the last dose?

Studies on how the body processes the medicine show that the mean plasma elimination half-life for the active ingredient is approximately 7 to 10 hours in adults with normal kidney function.

Q: Can Pixal be taken with antacids or heartburn medication?

Official labeling does not include documented interactions between Pixal and common antacids or heartburn medications.

Q: Does Pixal have different recommendations for use in men versus women?

Official pharmacokinetic studies examined drug processing based on gender. These studies indicate there are no differences in how the drug is processed that would necessitate different dosing recommendations for men and women with normal renal function.

Q: Are there official warnings about combining Pixal with opioid pain medications?

Yes, official regulatory labeling includes a warning about combining Pixal with Central Nervous System (CNS) depressants, which is the class of medicines that includes opioid pain medications. The concern is the potential for additive effects, such as increased drowsiness and reduced alertness.

Q: Can patients with liver impairment safely use Pixal?

According to official documents, because the medicine is primarily eliminated by the kidneys, no dosage adjustment is required for patients who have only hepatic impairment (liver problems).

Q: Does Pixal cause changes in appetite?

Official reports of adverse reactions list both increased appetite and decreased appetite (anorexia) among the events reported post-marketing.

Q: Does Pixal interact with any common herbal teas or remedies?

Official documents state that specific interaction studies have not been conducted between Pixal and common herbal teas or remedies.

How should Pixal be stored and disposed of?

Pixal (Levocetirizine) must be stored strictly according to the conditions defined in the official regulatory documents to maintain its stability.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Handling The oral solution formulation must not be frozen.
Protection Keep the medication in its original, tightly closed container and protect the tablets from moisture.

Safety and Disposal

All forms of Pixal must be stored out of the sight and reach of children as a mandatory safety requirement.

Official disposal protocols require that the unused or expired medication not be thrown into household trash or wastewater. Instead, it must be returned to a pharmacy or an approved medicine take-back program for proper environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pixal found in:

A-Z Index: